| Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04428333) | GlaxoSmithKline | 2020-08-12 |
| A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) (NCT04449029) | GlaxoSmithKline | 2020-07-27 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Melrilimab (GSK3772847) in Healthy Participants (NCT04366349) | GlaxoSmithKline | 2020-07-21 |
| Linerixibat Long-term Safety, and Tolerability Study (NCT04167358) | GlaxoSmithKline | 2020-07-14 |
| Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors (NCT04446351) | GlaxoSmithKline | 2020-06-25 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM (NCT07084896) | GlaxoSmithKline | 2020-06-08 |
| Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease (NCT04376684) | GlaxoSmithKline | 2020-05-28 |
| Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) (NCT04333147) | GlaxoSmithKline | 2020-05-12 |
| Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT04246047) | GlaxoSmithKline | 2020-05-07 |
| Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) (NCT04187144) | GlaxoSmithKline | 2020-04-23 |
| Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China (NCT04853225) | GlaxoSmithKline | 2020-04-22 |
| Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04162210) | GlaxoSmithKline | 2020-04-02 |
| Bioequivalence (BE) Study of Test Griseofulvin 500 Milligram (mg) Tablets Versus Reference and Dose Proportionality Study of Test Griseofulvin 250 mg and 500 mg Tablets Under Fed Conditions (NCT04318535) | GlaxoSmithKline | 2020-01-13 |
| Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma (NCT04091126) | GlaxoSmithKline | 2019-12-18 |
| A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04177823) | GlaxoSmithKline | 2019-12-09 |
| A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response (NCT04176939) | GlaxoSmithKline | 2019-12-09 |
| Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of GSK2330811 in Healthy Japanese Participants (NCT04138043) | GlaxoSmithKline | 2019-12-05 |
| Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) (NCT04179032) | GlaxoSmithKline | 2019-11-28 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM (NCT07217119) | GlaxoSmithKline | 2019-11-26 |
| Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04128696) | GlaxoSmithKline | 2019-11-21 |
| A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women (NCT04138056) | GlaxoSmithKline | 2019-11-05 |
| Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants (NCT04126213) | GlaxoSmithKline | 2019-11-05 |
| Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors (NCT04134728) | GlaxoSmithKline | 2019-10-31 |
| Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level (NCT04133909) | GlaxoSmithKline | 2019-10-30 |
| Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects (NCT04136145) | GlaxoSmithKline | 2019-10-28 |
| A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant (NCT04006808) | GlaxoSmithKline | 2019-10-25 |
| Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study (NCT04052620) | GlaxoSmithKline | 2019-10-24 |
| A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea (NCT04010539) | GlaxoSmithKline | 2019-10-21 |
| A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI) (NCT04020341) | GlaxoSmithKline | 2019-10-17 |
| Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers (NCT04114656) | GlaxoSmithKline | 2019-10-15 |
| Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04126200) | GlaxoSmithKline | 2019-10-07 |
| A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks (NCT04050722) | GlaxoSmithKline | 2019-10-07 |
| Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM (NCT06160609) | GlaxoSmithKline | 2019-10-07 |
| Efficacy of Manual Toothbrushes in Removing Dental Plaque (NCT04025684) | GlaxoSmithKline | 2019-09-30 |
| Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants (NCT04095286) | GlaxoSmithKline | 2019-09-30 |
| Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer (NCT02964507) | GlaxoSmithKline | 2019-09-26 |
| A Study to Test GlaxoSmithKline's (GSK) Respiratory Syncytial Virus RSV Candidate Vaccine's Safety and Immune Response in Japanese Older Adults (NCT04090658) | GlaxoSmithKline | 2019-09-25 |
| Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster (NCT04091451) | GlaxoSmithKline | 2019-09-17 |
| Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects (NCT04079790) | GlaxoSmithKline | 2019-09-04 |
| A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion (NCT04006795) | GlaxoSmithKline | 2019-08-28 |
| A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults (NCT04062669) | GlaxoSmithKline | 2019-08-13 |
| Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years (NCT04026009) | GlaxoSmithKline | 2019-08-05 |
| Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) (NCT03457701) | GlaxoSmithKline | 2019-07-30 |
| Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks (NCT03954743) | GlaxoSmithKline | 2019-07-19 |
| Dental Plaque Removal Ability of Prototype Power Toothbrush Versus a Manual Toothbrush in Healthy Participants (NCT03809910) | GlaxoSmithKline | 2019-07-08 |
| Pharmacokinetics (PKs) and Metabolism of Radiolabelled Linerixibat (NCT03992014) | GlaxoSmithKline | 2019-07-08 |
| Legend: TRELEGY Real World Chronic Obstructive Pulmonary Disease (COPD) Effectiveness Study (NCT03949842) | GlaxoSmithKline | 2019-06-27 |
| Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan (NCT03957577) | GlaxoSmithKline | 2019-06-13 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects (NCT03965533) | GlaxoSmithKline | 2019-06-10 |
| Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) (NCT03970837) | GlaxoSmithKline | 2019-06-05 |
| Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients (NCT03018808) | GlaxoSmithKline | 2019-06-03 |
| A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance (NCT03614676) | GlaxoSmithKline | 2019-05-30 |
| Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (NCT03980483) | GlaxoSmithKline | 2019-05-16 |
| Study to Characterize the Efficacy of a Dual Active Dentifrice for the Relief of Dentin Hypersensitivity (NCT03943095) | GlaxoSmithKline | 2019-05-13 |
| Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative Colitis (NCT03893565) | GlaxoSmithKline | 2019-05-06 |
| Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects (NCT03874234) | GlaxoSmithKline | 2019-04-30 |
| Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine (NCT03894969) | GlaxoSmithKline | 2019-04-23 |
| Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque Accumulation (NCT03703245) | GlaxoSmithKline | 2019-04-17 |
| Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV (NCT03636906) | GlaxoSmithKline | 2019-04-08 |
| Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection (NCT03866187) | GlaxoSmithKline | 2019-03-28 |
| An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis (NCT03557281) | GlaxoSmithKline | 2019-03-22 |
| Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT03848845) | GlaxoSmithKline | 2019-03-14 |
| An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments (NCT03828292) | GlaxoSmithKline | 2019-03-14 |
| A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors (NCT03843359) | GlaxoSmithKline | 2019-03-12 |
| Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a (NCT03697824) | GlaxoSmithKline | 2019-02-25 |
| Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants (NCT02141204) | GlaxoSmithKline | 2019-02-20 |
| Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States (NCT03973905) | GlaxoSmithKline | 2019-02-15 |
| A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults (NCT03824236) | GlaxoSmithKline | 2019-02-05 |
| To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive (NCT03807700) | GlaxoSmithKline | 2019-02-04 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) (NCT03739710) | GlaxoSmithKline | 2019-01-24 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1 (NCT05553808) | GlaxoSmithKline | 2019-01-24 |
| A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine (NCT03803202) | GlaxoSmithKline | 2019-01-24 |
| To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function (NCT03804710) | GlaxoSmithKline | 2019-01-22 |
| A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults (NCT03814590) | GlaxoSmithKline | 2019-01-21 |
| Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) (NCT03446612) | GlaxoSmithKline | 2019-01-10 |
| A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers (NCT03709810) | GlaxoSmithKline | 2019-01-07 |
| Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab (NCT03709706) | GlaxoSmithKline | 2018-12-31 |
| GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors (NCT03693612) | GlaxoSmithKline | 2018-11-26 |
| First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors (NCT03681951) | GlaxoSmithKline | 2018-11-16 |
| A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women (NCT03674177) | GlaxoSmithKline | 2018-10-30 |
| First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) (NCT03666988) | GlaxoSmithKline | 2018-10-22 |
| Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT03614728) | GlaxoSmithKline | 2018-10-16 |
| A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin (NCT03640832) | GlaxoSmithKline | 2018-10-15 |
| A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea (NCT03671369) | GlaxoSmithKline | 2018-10-02 |
| A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 (NCT03649412) | GlaxoSmithKline | 2018-09-26 |
| Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting (NCT03595930) | GlaxoSmithKline | 2018-09-21 |
| To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT03544281) | GlaxoSmithKline | 2018-09-20 |
| A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age (NCT03433482) | GlaxoSmithKline | 2018-08-30 |
| First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect (NCT03627494) | GlaxoSmithKline | 2018-08-30 |
| A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults (NCT03527173) | GlaxoSmithKline | 2018-08-29 |
| A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma (NCT03562195) | GlaxoSmithKline | 2018-08-29 |
| Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study (NCT03629886) | GlaxoSmithKline | 2018-08-22 |
| Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants (NCT03621670) | GlaxoSmithKline | 2018-07-27 |
| Sensor and Electronic Health Records (EHR) Integration Pilot Study (NCT03357341) | GlaxoSmithKline | 2018-07-23 |
| Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis) (NCT03568942) | GlaxoSmithKline | 2018-07-23 |
| BOTOX® Drug Use Investigation (Spasmodic Dysphonia) (NCT03543150) | GlaxoSmithKline | 2018-07-20 |
| A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty (NCT03497039) | GlaxoSmithKline | 2018-07-19 |
| Phase I Study of GSK2982772 in Japanese Healthy Male Participants (NCT03590613) | GlaxoSmithKline | 2018-07-19 |
| Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects (NCT03567499) | GlaxoSmithKline | 2018-07-12 |
| Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years (NCT03587207) | GlaxoSmithKline | 2018-07-09 |